使Ifitm1

Yu Yao1,2, Kun Xi1, Shaohu Xu2

  • 1Department of Orthopedics, The First Affiliated Hospital of Soochow University, Orthopedic Institute, Soochow University, Suzhou, Jiangsu, China.

PubMed
概括

这项研究确定了粒细胞子集和Ifitm1基因是脊髓损伤 (SCI) 分子机制的关键参与者. Ifitm1被提议作为治疗点,NVP-AUY922被确定为潜在的候选药物.

相关概念视频